An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation
Life Science Alliance · 2025
DOI: 10.26508/lsa.202403014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Mónica Román-Trufero und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland. Hauptthemen laut MEDLINE: Ribosomes, Protein Biosynthesis, Protein Serine-Threonine Kinases, RNA, Messenger. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK Advanced Clinician Scientist Fellowship, Cancer Research UK Small Molecule Drug Discovery Award, Cancer Research UK.
Abstract (Originalsprache)
The integrated stress response (ISR) is a corrective physiological programme to restore cellular homeostasis that is based on the attenuation of global protein synthesis and a resource-enhancing transcriptional programme. GCN2 is the oldest of four kinases that are activated by diverse cellular stresses to trigger the ISR and acts as the primary responder to amino acid shortage and ribosome collisions. Here, using a broad multi-omics approach, we uncover an ISR-independent role of GCN2. GCN2 inhibition or depletion in the absence of discernible stress causes excessive protein synthesis and ribosome biogenesis, perturbs the cellular translatome, and results in a dynamic and broad loss of metabolic homeostasis. Cancer cells that rely on GCN2 to keep protein synthesis in check under conditions of full nutrient availability depend on GCN2 for survival and unrestricted tumour growth. Our observations describe an ISR-independent role of GCN2 in regulating the cellular proteome and translatome and suggest new avenues for cancer therapies based on unleashing excessive mRNA translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
- Hugh and Josseline Langmuir Centre for Myeloma Research, Department of Immunology and Inflammation, Imperial College London, London, UK.
- The Francis Crick Institute, London, UK.
- Department of Mathematics, Imperial College London, London, UK.
- Clinical Bioinformatics Research, London, UK.
- Department of Surgery and Cancer, Imperial College London, London, UK.
ORCID-Profile: Istvan T Kleijn, Jinglin Zhou, Paula Saavedra-García, Marilena Christoforou, Douglas Lamont, Marek Gierlinski, Glenn R Masson, Vahid Shahrezaei, Holger W Auner
Förderung
- Cancer Research UK Advanced Clinician Scientist Fellowship
- Cancer Research UK Small Molecule Drug Discovery Award
- Cancer Research UK
- Fondation ISREC
- Lausanne University Hospital
- University of Dundee
Zitieren
APA
Román-Trufero, M., Kleijn, I. T., Blighe, K., Zhou, J., Saavedra-García, P., Gaffar, A., Christoforou, M., Bellotti, A., Abrahams, J., Atrih, A., Lamont, D., Gierlinski, M., Jayaprakash, P., Michel, A. M., Aboagye, E. O., Yuneva, M., Masson, G. R., Shahrezaei, V., & Auner, H. W. (2025). An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation. Life Science Alliance. https://doi.org/10.26508/lsa.202403014
Vancouver
Román-Trufero M, Kleijn IT, Blighe K, Zhou J, Saavedra-García P, Gaffar A, et al. An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation. Life Science Alliance. 2025. doi:10.26508/lsa.202403014
BibTeX
@article{RomnTrufero2025,
author = {Román-Trufero, Mónica and Kleijn, Istvan T and Blighe, Kevin and Zhou, Jinglin and Saavedra-García, Paula and Gaffar, Abigail and Christoforou, Marilena and Bellotti, Axel and Abrahams, Joel and Atrih, Abdelmadjid and Lamont, Douglas and Gierlinski, Marek and Jayaprakash, Pooja and Michel, Audrey M and Aboagye, Eric O and Yuneva, Mariia and Masson, Glenn R and Shahrezaei, Vahid and Auner, Holger W},
title = {An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202403014}
}
EUVIMED